415 Capital
Share
N°01 / About
About 415 Capital
Specialist medtech VC investing in breakthrough medical innovation for chronic diseases, with emphasis on cardio and neurovascular disorders. Clinical through commercial stage in Europe, Israel and North America, EUR 5-15M per company. Excludes biotech/pharma, healthcare services and wellness.
N°02 / Thesis
Investment Focus
Location / RegionGermany
Funding StagePre-Seed
Industry Focus
MedTech
Robotics & Automation
Investor Signals Profile
active
Sweet Spot
Cardiovascular/neurovascular clinical-stage MedTech founder
39 signals on 415 Capital
24 bullish · 3 contrarian · 5 pitch do's · 3 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.
Michael's Network
People
Key People
Frederik Groenewegen, Frank Groenewegen, David Thompson
Frederik GroenewegenCo-Founder and General Partner
David ThompsonCo-Founder, General Partner and Chief Financial Officer
Azin ParhizgarManaging Director, US
Ruben OsnabruggePartner & Chief Medical Officer